Search Results - "Shamalov, N. A"

Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Mexidol in Prolonged Sequential Therapy of Patients in the Acute and Early Recovery Stages of Hemispheric Stroke (the EPICA study) by Stakhovskaya, L. V., Shamalov, N. A., Khasanova, D. R., Mel’nikova, E. V., Agaf’ina, A. S., Golikov, K. V., Bogdanov, E. I., Yakupova, A. A., Roshkovskaya, L. V., Lukinykh, L. V., Lokshtanova, T. M., Poverennova, I. E., Shchepankevich, L. A.

“…Objectives. To assess the efficacy and safety of prolonged sequential therapy with Mexidol in patients with hemispheric ischemic stroke (IS) in the acute and…”
Get full text

Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care by Gusev, E I, Martynov, M Yu, Boyko, A N, Voznyuk, I A, Latsh, N Yu, Sivertseva, S A, Spirin, N N, Shamalov, N A

“…Novel coronavirus SARS-CoV-2 and COVID-19, besides affecting the respiratory system, may lead to central and peripheral nervous system disorders and also cause…”
Get more information

Problems of selecting an anticoagulant for secondary stroke prevention in patients with atrial fibrillation by Gusev, V. V., Lvova, O. A., Shamalov, N. A.

“…The article describes the urgent problem of ischemic stroke prevention in patients with atrial fibrillation. It is proved that ischemic stroke in combination…”
Get full text

Oncologic Diseases as a Risk Factor for Cryptogenic Stroke by Ramazanov, G. R., Kovaleva, E. A., Shamalov, N. A.

“…Background. Acute cerebrovascular accidents in general, and ischemic stroke (IS) in particular, are multifactorial diseases with extremely heterogeneous and…”
Get full text

Genetic Features of Cerebral Stroke by Khasanova, L. T., Stakhovskaya, L. V., Koltsova, E. A., Shamalov, N. A.

“…Recent years have seen an increase in interest in the identification of additional genetic factors for cerebral stroke. A large number of studies have been run…”
Get full text

The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care by Gusev, E. I., Martynov, M. Yu, Boyko, A. N., Voznyuk, I. A., Latsh, N. Yu, Sivertseva, S. A., Spirin, N. N., Shamalov, N. A.

“…The new coronavirus SARS-CoV-2 and the disease it causes COVID-19 involves not only respiratory system damage, but can also lead to disorders of the central…”
Get full text

Practical use of idarucizumab by Ramazanov, G. R., Kovaleva, E. A., Klychnikova, E. V., Petrikov, S. S., Shamalov, N. A., Aliev, I. S., Shevchenko, E. V.

“…The number of patients with indications for direct oral anticoagulants (DOACs) to prevent thrombotic events is steadily growing. However, in 1,1-2,2% of cases,…”
Get full text

Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19 by Shamalov, N. A., Klimov, L. V., Soldatov, M. A., Kiseleva, T. V., Shamalova, V. N., Marskaya, N. A., Lyang, O. V.

“…The incidence of neurological complications in COVID-19 can reach 8–10% of all cases of new coronavirus infection; acute cerebrovascular accidents (ACA)…”
Get full text

The role of smoking in the development of strokes at a young age by Gusev, V. V., Medvedev, D. A., Lvova, O. A., Shamalov, N. A., Kovtun, O. P.

“…Stroke in young patients is a disease based on a number of known specific non-modifiable factors (extracranial artery dissection, thrombophilia, open oval…”
Get full text

Association between Polymorphisms in the Phosphodiesterase 4D (PDE4D) Gene and the Development of Cerebral Stroke in Patients in the Moscow Population by Skvortsova, V. I., Limborskaya, S. A., Shetova, I. M., Slominskii, P. A., Shamalov, N. A., Bondarenko, E. A., Timofeev, D. Yu

“…Two polymorphisms in the PDE4D gene – SNP41 (rs152312) and SNP87 (rs2910829), encoding phosphodiesterase 4D – were studied in patients during the acute period…”
Get full text

Fibrinogen concentration in the evaluation of safety and efficiency of thrombolytic therapy in patients with ischemic stroke by Liang, O V, Kochetov, A G, Shamalov, N A, Anisimov, K V, Ramazanov, G R, Arkhipkin, A A, Novozhenova, Iu V, Kustova, M A, Podshivalov, D C, Egorov, V O

“…To identify and investigate threshold fibrinogen concentrations as predictors of hemorrhagic transformation (HT), fatal outcome (FO), and the efficiency of…”
Get full text

Anamnestic, clinical and laboratory features of the acute period of ischemic stroke in young patients by Gusev, V. V., Kovtun, O. P., Lvova, O. A., Partylova, E. A., Sergeev, A. P., Sergeeva, M. V., Yanchuk, I. T., Dobrazova, D. A., Suvorkov, P. A., Shamalov, N. A.

“…Objective: to study the anamnestic, clinical and laboratory features of the acute period of ischemic stroke (IS) and to determine the risk factors for its…”
Get full text

Phosphodiesterase 4D (PDE4D) gene polymorphism in patients with acute stroke from Moscow by Bondarenko, E. A, Tupitsina, T. V, Slominsky, P. A, Shetova, I. M, Shamalov, N. A, Botsina, A. Yu, Skvortsova, V. I, Limborska, S. A

“…Two PDE4D gene polymorphisms [SNP41 (rs152312 and SNP87 (rs2910829)] were studied in patients with acute stroke (n = 577) and in control sample (n = 270)…”
Get full text

Control of dyslipidemia in the prevention of recurrent ischemic cerebrovascular accidents (expert opinion) by Tanashyan, M. M., Shamalov, N. A., Voznyuk, I. A., Yanishevsky, S. N., Vinogradov, O. I., Khasanova, D. R., Tikhomirova, O. V., Parfenov, V. A., Oshchepkova, E. V., Ezhov, M. V., Gurevich, V. S., Arkhipov, V. V.

“…On July 6, 2022, an interdisciplinary meeting of the Expert Council was held on the topic "Control of dyslipidemia in the prevention of acute and recurrent…”
Get full text

Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident by Boytsov, S. A., Piradov, M. A., Tanashyan, M. M., Voznjouk, I. A., Ezhov, M. V., Oschepkova, E. V., Sergienko, I. V., Shamalov, N. A., Yanishevskiy, S. N.

“…The existing system of medical care for patients with acute cerebrovascular accident of atherothrombotic genesis, namely lipid metabolism disorders, the modern…”
Get full text

Genetic characteristics of stroke by Khasanova, L T, Stakhovskaya, L V, Koltsova, E A, Shamalov, N A

“…In the recent years there is a growing interest in identification of additional genetic factors of stroke. A growing body of evidence supports the role of…”
Get more information

Association of polymophisms of renin-angiotensin and hemostasis system genes with ischemic stroke in Russians from central Russia by Usacheva, M. A., Nasedkina, T. V., Ikonnikova, A. Yu, Kulikov, A. V., Chudinov, A. V., Lysov, Yu. P., Bondarenko, E. V., Slominskii, P. A., Shamalov, N. A., Shetova, I. M., Limborskaya, S. A., Zasedatelev, A. S., Skvortsova, V. I.

“…The allele and genotype frequencies of 14 SNPs of renin-angiotensin ( REN, AGT, AGTR1, AGTR2, BKR2 , and ADRB2 ) and hemostasis ( FGB, F2, F5, F7, ITGB3,…”
Get full text

Etiology of Cryptogenic Stroke by Ramazanov, G. R., Magomedov, T. A., Khamidova, L. T., Rybalko, N. V., Petrikov, S. S., Shamalov, N. A.

“…Ischemic stroke is a heterogeneous syndrome with a plurality of potential etiological factors. The routine diagnosis does not always allow the cause of acute…”
Get full text

An analysis of the dynamics of the main types of stroke and pathogenetic variants of ischemic stroke by Shamalov, N A, Stakhovskaya, L V, Klochihina, O A, Polunina, O S, Polunina, E A

“…To analyze the main changes in the prevalence of stroke types and pathogenetic variants of ischemic stroke based on the data obtained from seven regions of the…”
Get more information

Endovascular treatment results in patients with large cerebral artery occlusions in a metropolis. Moscow Stroke Registry data over 2019 by Skrypnik, D. V., Anisimov, K. V., Botsina, A. Yu, Kiseleva, T. V., Grachev, S. P., Shamalov, N. A., Vasilyeva, E. Yu, Shpektor, A. V.

“…Objective : to assess results from the Stroke Network created on the basis of the Infarction Network in the metropolis Moscow for endovascular treatment in…”
Get full text